Downloads: 0 | Views: 218

Review Papers | Cancer Science | India | Volume 11 Issue 8, August 2022 | Popularity: 4.2 / 10

Rate This Article!      

Chemotherapy Have No Role in the Management of Soft Tissue Sarcoma Review Article! Radiation Oncologist Perspective

Major Dr Mirza Qaiserbaig, Dr Anshu Kumar Goel

Abstract: Soft tissue sarcomas are less common cancer, merely 1% of all cancer in human body so far as site specific is concern more than 75% cases of STS occurs in adult 40% arises from lower extremities and 30% arises from trunk and retroperitoneum, 20% arises from upper extremities, 10% STS occurs in head and neck region, due never radiotherapy techniques as well as advancement in field of surgery now survival rate of soft tissue sarcoma drastically increased, chemotherapy role is yet not Clearfield in different research studies done so far, so we will be reviewing from start to end of soft tissue sarcomas management. The preliminary data from the EORTC 62931, the largest trial of adjuvant chemotherapy for STS, has failed to demonstrate any benefit from chemotherapy in local control, progression free survival or overall survival in patients treated with adjuvant chemotherapy henceforth author considered role of adjuvant chemotherapy remains unproven.

Keywords: Soft tissue sarcomas, Radiotherapy, Surgery. Chemotherapy

Edition: Volume 11 Issue 8, August 2022

Pages: 1292 - 1297

DOI: https://www.doi.org/10.21275/MR22824043757

Make Sure to Disable the Pop-Up Blocker of Web Browser

Click to Cite this Article

Similar Articles